BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37772396)

  • 1. Metabolomics analyses of cancer tissue from patients with colorectal cancer.
    Kang C; Zhang J; Xue M; Li X; Ding D; Wang Y; Jiang S; Chu FF; Gao Q; Zhang M
    Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study.
    Liesenfeld DB; Grapov D; Fahrmann JF; Salou M; Scherer D; Toth R; Habermann N; Böhm J; Schrotz-King P; Gigic B; Schneider M; Ulrich A; Herpel E; Schirmacher P; Fiehn O; Lampe JW; Ulrich CM
    Am J Clin Nutr; 2015 Aug; 102(2):433-43. PubMed ID: 26156741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
    Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the levels of N-nitrosamine compounds and untargeted metabolomics in patients with colorectal cancer.
    Luo Z; Wang H; Lin S; Liao L; Cai L; Zhang X; Tan Y; Shen M
    Anal Bioanal Chem; 2022 May; 414(11):3483-3496. PubMed ID: 35174409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans.
    Manna SK; Tanaka N; Krausz KW; Haznadar M; Xue X; Matsubara T; Bowman ED; Fearon ER; Harris CC; Shah YM; Gonzalez FJ
    Gastroenterology; 2014 May; 146(5):1313-24. PubMed ID: 24440673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.
    Tian Y; Xu T; Huang J; Zhang L; Xu S; Xiong B; Wang Y; Tang H
    Sci Rep; 2016 Feb; 6():20790. PubMed ID: 26876567
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
    Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global metabolomics profiling of colorectal cancer in Malaysian patients.
    Amir Hashim NA; Ab-Rahim S; Wan Ngah WZ; Nathan S; Ab Mutalib NS; Sagap I; A Jamal AR; Mazlan M
    Bioimpacts; 2021; 11(1):33-43. PubMed ID: 33469506
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
    Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
    J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the anti-metastatic effects of Astragalus mongholicus Bunge-Curcuma aromatica Salisb. on colorectal cancer: A network-based metabolomics and pharmacology approach.
    Liang ZQ; Bian Y; Gu JF; Yin G; Sun RL; Liang Y; Wan LL; Yin QH; Wang X; Gao J; Zhao F; Tang C
    Phytomedicine; 2023 Jun; 114():154772. PubMed ID: 37015187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
    Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
    Cancer Metab; 2016; 4():11. PubMed ID: 27275383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
    Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
    Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics and 16S rRNA sequencing of human colorectal cancers and adjacent mucosa.
    Loke MF; Chua EG; Gan HM; Thulasi K; Wanyiri JW; Thevambiga I; Goh KL; Wong WF; Vadivelu J
    PLoS One; 2018; 13(12):e0208584. PubMed ID: 30576312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing metabolic changes in human colorectal cancer.
    Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
    Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer.
    Fan X; Rao J; Zhang Z; Li D; Cui W; Zhang J; Wang H; Tou F; Zheng Z; Shen Q
    Cell Physiol Biochem; 2018; 46(4):1317-1330. PubMed ID: 29689551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue amino acid profile could be used to differentiate advanced adenoma from colorectal cancer.
    Gao P; Zhou C; Zhao L; Zhang G; Zhang Y
    J Pharm Biomed Anal; 2016 Jan; 118():349-355. PubMed ID: 26595283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.